Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
Organisation › Details

Ona Therapeutics (ES)

ONA Therapeutics, with headquarters in the Barcelona Science Park (PCB), Barcelona, Spain, is a biotech company that specializes in the discovery and development of therapeutic biologics targeting lipid metabolism to treat advanced cancer. The company was founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, as a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine. In 2020 ONA Therapeutics raised a EUR 30 million Series A investment round from an international syndicate of life sciences Specialist investors. *


Period Start 2019-01-01 established (s-off)
  Predecessor IRB Barcelona – Institute for Research in Biomedicine
Products Industry biopharmaceutical
  Industry 2 drug development
Persons Person Vanhooren, Valerie (Ona Therapeutics 202006 CEO + Co-Founder)
  Person 2 Casado, Pilar (Ikon Partner 202404 Founding Partner + Deepull Diagnostics CFO +Ona Therapeutics CFO)
Region Region Barcelona
  Country Spain (España)
  Street 4 Carrer de Baldiri Reixac
Parc Científic de Barcelona
  City 08028 Barcelona
    Address record changed: 2024-01-05
Basic data Employees n. a.
    * Document for »About Section«: Ona Therapeutics. (12/2/21). "Press Release: Ona Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors". Barcelona.
Record changed: 2023-07-10


Picture Demy-Colton BioFuture 2024 NYC Game Changers 650x200px

More documents for Ona Therapeutics (ES)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top